These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23266179)

  • 21. An optimised small-molecule stabiliser of the 14-3-3-PMA2 protein-protein interaction.
    Richter A; Rose R; Hedberg C; Waldmann H; Ottmann C
    Chemistry; 2012 May; 18(21):6520-7. PubMed ID: 22467351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors.
    Li B; Rong D; Wang Y
    Curr Top Med Chem; 2019; 19(21):1872-1876. PubMed ID: 31696799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.
    Kuenemann MA; Sperandio O; Labbé CM; Lagorce D; Miteva MA; Villoutreix BO
    Prog Biophys Mol Biol; 2015 Oct; 119(1):20-32. PubMed ID: 25748546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
    Block P; Weskamp N; Wolf A; Klebe G
    Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.
    Zinzalla G; Thurston DE
    Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based Tethering.
    Wolter M; Valenti D; Cossar PJ; Levy LM; Hristeva S; Genski T; Hoffmann T; Brunsveld L; Tzalis D; Ottmann C
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21520-21524. PubMed ID: 32816380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stabilization of protein-protein interaction complexes through small molecules.
    Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
    Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-binding small molecules as inhibitors of transcription factors.
    Leung CH; Chan DS; Ma VP; Ma DL
    Med Res Rev; 2013 Jul; 33(4):823-46. PubMed ID: 22549740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendrimer space exploration: an assessment of dendrimers/dendritic scaffolding as inhibitors of protein-protein interactions, a potential new area of pharmaceutical development.
    Mignani S; El Kazzouli S; Bousmina MM; Majoral JP
    Chem Rev; 2014 Jan; 114(2):1327-42. PubMed ID: 24127777
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure-based design of small-molecule protein-protein interaction modulators: the story so far.
    Falchi F; Caporuscio F; Recanatini M
    Future Med Chem; 2014 Mar; 6(3):343-57. PubMed ID: 24575969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecules modulation of 14-3-3 protein-protein interactions.
    Mori M; Vignaroli G; Botta M
    Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors.
    Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R
    Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
    Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
    J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress in the discovery and development of negative allosteric modulators of mGluR5.
    Lindsley CW; Emmitte KA
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):446-57. PubMed ID: 19562641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural aspects of small-molecule inhibition of methyllysine reader proteins.
    Milosevich N; Warmerdam Z; Hof F
    Future Med Chem; 2016 Sep; 8(13):1681-702. PubMed ID: 27577975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the AmpC β-lactamase binding site and identification of inhibitors with novel scaffolds.
    Chan FY; Neves MA; Sun N; Tsang MW; Leung YC; Chan TH; Abagyan R; Wong KY
    J Chem Inf Model; 2012 May; 52(5):1367-75. PubMed ID: 22559726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.